Recommendations for the Use of Abatacept in Patients with rheumatoid Arthritis

被引：0
|
作者：
Gaubitz, M. [1 ]
Krueger, K. [2 ]
Haas, J. -P. [3 ]
机构：
[1] WWU Munster, Akad Manuelle Therapie, Munster, Germany
[2] Praxiszentrum, D-81541 Munich, Germany
[3] Kinderklin Garmisch Partenkirchen, Deutsch Zentrum Kinder & Jugendrheumatol, Garmisch Partenkirchen, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2014年 / 73卷 / 10期
关键词：
JUVENILE IDIOPATHIC ARTHRITIS; COSTIMULATION MODULATOR ABATACEPT; LONG-TERM SAFETY; INADEQUATE RESPONSE; DOUBLE-BLIND; PHASE IIIB; SUBCUTANEOUS ABATACEPT; BIOLOGICAL AGENTS; GERMAN SOCIETY; AIM TRIAL;
D O I：
10.1007/s00393-014-1373-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：942 / 949
页数：8
相关论文
共 50 条
  • [31] Abatacept in the treatment of rheumatoid arthritis
    Maya H Buch
    Edward M Vital
    Paul Emery
    Arthritis Research & Therapy, 10
  • [32] Rituximab and abatacept in rheumatoid arthritis
    Gomez Centeno, Toni
    REUMATOLOGIA CLINICA, 2009, 5 : 77 - 81
  • [33] Abatacept treatment for rheumatoid arthritis
    Schiff, Michael
    RHEUMATOLOGY, 2011, 50 (03) : 437 - 449
  • [34] Abatacept for the treatment of rheumatoid arthritis
    Pombo-Suarez, Manuel
    Gomez-Reino, Juan J.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (04) : 319 - 326
  • [35] Abatacept: A Review in Rheumatoid Arthritis
    Hannah A. Blair
    Emma D. Deeks
    Drugs, 2017, 77 : 1221 - 1233
  • [36] Abatacept: A Review in Rheumatoid Arthritis
    Blair, Hannah A.
    Deeks, Emma D.
    DRUGS, 2017, 77 (11) : 1221 - 1233
  • [37] Abatacept in the treatment of rheumatoid arthritis
    Posadas, Augusto
    Lisse, Jeffrey
    Sarkar, Sujata
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (01) : 9 - 17
  • [38] Abatacept in the treatment of rheumatoid arthritis
    Buch, Maya H.
    Vital, Edward M.
    Emery, Paul
    ARTHRITIS RESEARCH & THERAPY, 2008, 10 (Suppl 1)
  • [39] Abatacept for subclinical rheumatoid arthritis
    Brooks, Helen
    Clark, Anna
    Van Epps, Heather
    LANCET RHEUMATOLOGY, 2022, 4 (01): : E18 - E18
  • [40] Use of Rituximab or Abatacept after Anti-TNF Discontinuation in Patients with Severe Rheumatoid Arthritis
    Barnabe, C.
    Hazlewood, G.
    Barr, S. G.
    Martin, L.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2564 - 2564
12345